A compounding leader takes issue with FDA's position that compounding is the production of a new drug that needs to be approved.
L.D. King
Advertisement
Articles by L.D. King
Advertisement
Latest Updated Articles
- FDA's stand on compounding is bad for R.Ph.s and patients
Published: December 10th 2007 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
The Pharmacist’s Expertise in Managing Pneumococcal Diseases, Vaccines
2
What TrumpRx Means for Independent Pharmacies and Their Patients
3
Addressing Clinical Challenges and Expanding Pharmacy Roles | Recap ASHP Midyear 2025
4
Oral Semaglutide Show Promise as New Benchmark for Diabetes Care, Cardiovascular Protection
5
